← Eichor
Study identifier: NCT07066228 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Bone Reconstruction With Autologous Bone Marrow Mesenchymal Stem Cells in Vitro to Repair Long Tubular Bone Defects

Condition: Defective Composite Restorations · Bone Cysts · Bone Defect  ·  Sponsor: The First Affiliated Hospital of Xinxiang Medical College

PhaseNA
Planned participants30
Who can joinAll sexes, 18 Years to 55 Years
Healthy volunteersNo

About this study

Commercial decalcified bone scaffolds were combined with autologous bone marrow mesenchymal stem cells to form tissue engineered bone in vitro to explore the effect of this tissue engineered bone in the clinical repair of long tubular bone defects in limbs.

This description comes directly from the study's public registry record.

Talk to the study team

Wenjie Ren  ·  8613937354075  ·  13937354075@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

The First Affiliated Hospital of Xinxiang Medical CollegeXinxiang, Henan, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07066228